Jobs I Know
Browse openings
Business & FinanceHybrid

Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Gilead SciencesEl Segundo, CA

$205,615–266,090/yr (other US); $226,185–292,710/yr (Bay Area)

Posted Oct 13, 2026

What you’d do

Lead global market access strategy for Kite's autoimmune cell therapy portfolio, supporting early and late-stage development programs and launch preparation. Hybrid role with 3 days onsite in El Segundo, Thousand Oaks, or Foster City, CA. Found on the employer's careers page on Oct 18, 2026. Apply through the link.

You’ll need

  • 3+ years supporting autoimmune disease programs
  • Experience in market access, medical affairs, or commercial strategy
  • Understanding of autoimmune treatment paradigms
  • Hybrid onsite 3 days/week in California

Our summary of the listing. The full listing has the details.

Know before you apply

Members see how long this job has really been open, how many people have applied, and people at Gilead Sciences to connect with on LinkedIn. It’s free.